Konstantin Laktionov
4PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 09, 2026
Patient-Reported Outcomes in FLAURA2: Osimertinib with or without Chemotherapy in Patients with Previously Untreated EGFR-Mutated Advanced Non-Small Cell Lung Cancer.Jhanelle E Gray, Konstantin Laktionov, Sang-We Kim
|Dec 02, 2023
CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer.Pasi A Jänne, David Planchard, Kunihiko Kobayashi
|Jan 31, 2023
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial.Roy S Herbst, Yi-Long Wu, Thomas John
|Nov 03, 2022
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.Melissa L Johnson, Byoung Chul Cho, Alexander Luft
Pageof 1
Frequent Collaborators
3 joint publications
Terufumi Kato
2 joint publications
Neha P Amin
2 joint publications
Chee Khoon Lee
2 joint publications
Kunihiko Kobayashi
1 joint publications
Muna Albayaty
1 joint publications
Byoung Chul Cho
1 joint publications
Luiz Henrique Araujo
1 joint publications
Haruhiro Saito
1 joint publications
Solange Peters
1 joint publications
Edward B Garon
